Cargando…
Immunogenicity to Biotherapeutics – The Role of Anti-drug Immune Complexes
Biological molecules are increasingly becoming a part of the therapeutics portfolio that has been either recently approved for marketing or those that are in the pipeline of several biotech and pharmaceutical companies. This is largely based on their ability to be highly specific relative to small m...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735944/ https://www.ncbi.nlm.nih.gov/pubmed/26870037 http://dx.doi.org/10.3389/fimmu.2016.00021 |